Monuril (Fosfomycin Trometamol)

Fosfomycin trometamol works by inhibiting the bacterial enzyme MurA, which is essential for the first step of peptidoglycan synthesis in the cell wall. By blocking this pathway, the drug weakens the bacterial wall, leading to cell lysis and death of the pathogen.

The prescribed dose of Monuril is determined by the treating clinician based on the patient’s condition, renal function, and local prescribing guidelines. The medication is typically given as a single oral dose, but the exact amount must be confirmed by a healthcare professional.

Safety data for fosfomycin trometamol in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made by the prescribing physician after evaluating the individual situation.

To order Monuril, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. The sales team will then provide pricing, availability, shipping details (including any cold‑chain requirements) and assist with import documentation.

Monuril offers a single‑dose oral regimen, which can improve adherence compared with multi‑day courses of drugs such as trimethoprim‑sulfamethoxazole or fluoroquinolones. Its unique mechanism targets MurA, providing activity against some resistant strains, though susceptibility testing remains essential to guide therapy.

Monuril should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in humid environments such as bathrooms.

Monuril is taken orally as a single dose, usually with a full glass of water. It can be taken with or without food, but patients should follow any specific instructions provided by their healthcare provider regarding timing relative to meals.

The most serious risks include severe allergic reactions such as anaphylaxis, skin disorders like Stevens‑Johnson syndrome, and Clostridioides difficile‑associated colitis. Patients should seek immediate medical attention if they experience rash, swelling, difficulty breathing, or persistent severe diarrhea.

Monuril should not be used by individuals with a known hypersensitivity to fosfomycin or any component of the formulation. Caution is also advised for patients with severe renal impairment, and it is generally avoided in children unless specifically prescribed by a pediatric specialist.